Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (PACTR202607649868973) titled 'Building Respiratory Evidence for AI Tools and Health Equity (BREATHE)' on July 28.
Study Type: Interventional
Study Design:
Single Group,Non-randomised,Allocation Sequence/Code was not concealed
Primary Sponsor: Gates Foundation
Condition:
Tuberculosis
Respiratory
Paediatrics
Tuberculosis
Respiratory
Paediatrics
Recruitment Status: Not Recruiting
Phase: Not Applicable
Date of First Enrollment: 01/08/2026
Target Sample Size: 18000
Countries of Recruitment:
India
Nigeria
South Africa
South Africa
South Africa
South Africa
South Africa
To know more, visit https://pactr.samrc.ac.za/TrialDisplay.a...